Richard W. Paul & Associates’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
27,127
+21,763
+406% +$1.18M 0.35% 77
2026
Q1
$337K Buy
5,364
+5,342
+24,282% +$427K 0.11% 139
2025
Q4
$2.1K Hold
22
﹤0.01% 261
2025
Q3
$2.15K Sell
22
-3,485
-99% -$361K ﹤0.01% 277
2025
Q2
$377K Sell
3,507
-774
-18% -$78.3K 0.14% 132
2025
Q1
$432K Sell
4,281
-58
-1% -$5.84K 0.17% 123
2024
Q4
$388K Buy
4,339
+624
+17% +$54.9K 0.14% 134
2024
Q3
$311K Buy
3,715
+69
+2% +$5.44K 0.11% 146
2024
Q2
$281K Sell
3,646
-20
-0.5% -$1.46K 0.11% 149
2024
Q1
$251K Sell
3,666
-178
-5% -$11.4K 0.1% 160
2023
Q4
$222K Sell
3,844
-136
-3% -$7.26K 0.09% 161
2023
Q3
$210K Sell
3,980
-161
-4% -$8.44K 0.1% 156
2023
Q2
$224K Sell
4,141
-36
-0.9% -$1.88K 0.1% 164
2023
Q1
$209K Buy
+4,177
New +$197K 0.1% 162

Other funds holding BSX

Richard W. Paul & Associates's BSX Position: Q2 2026 in Review

Richard W. Paul & Associates increased its Boston Scientific (BSX) stake by 406% in Q2 2026, buying an estimated $1.18M and bringing the position to 27,127 shares worth $1.16M. The position accounts for 0.35% of the portfolio, ranked #77.

Richard W. Paul & Associates first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Richard W. Paul & Associates held 27,127 shares of Boston Scientific worth $1.16M as of Q2 2026.
  • Richard W. Paul & Associates bought 21,763 Boston Scientific shares in Q2 2026, an estimated $1.18M.
  • Boston Scientific made up 0.35% of Richard W. Paul & Associates's portfolio in Q2 2026, its #77 holding.
  • Richard W. Paul & Associates first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Richard W. Paul & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.